Aristolochia bracteolata Lam.’s Toxicity Profile and Neuroprotective Effects in Mice with Memory Impairment Triggered by Scopolamine
Dhivya P. Sundaram1, Swathy Govindaswamy2★, Sridevi Sangeetha K. S.3, Palanisamy Selvamani4, Subbiah Latha4★ Corresponding author
- 1Department of Biomedical Science, Bharathidasan University, Tiruchirappalli, Tamil Nadu, India.
- 2Department of Pharmacy Practice, KMCH College of Pharmacy, Coimbatore, Tamil Nadu, India.
- 3Department of Pharmacology, Faculty of Allied Health Sciences, Meenakshi Academy of Higher Education and Research, Kanchipuram, Tamil Nadu, India.
- 4Department of Pharmaceutical Technology, Centre for Excellence in Nanobio Translational Research Center, Anna University, Bharathidasan Institute of Technology Campus, Tiruchirappalli, Tamil Nadu, India.
CORRESPONDENCE
Swathy Govindaswamy
Department of Pharmacy Practice, KMCH College of Pharmacy, Coimbatore, Tamil Nadu 641048, India.
Received: 10-10-2023; Revised: 30-10-2023; Accepted: 02-11-2023.
Volume 14, Issue 3 · pp. 238–245 · PUBLISHED 2023 · DOI: 10.1177/0976500X231215933
View on J Pharmacol. Pharmacother. original site ↗
ABSTRACT
Aim: The present study aims to investigate the toxicity profile and neuroprotective effect of ethanol crude extract of Aristolochia bracteolata (EEAB) leaves in mice. Materials and Methods: EEAB was subjected to preliminary phytochemical screening and gas chromatography–mass spectrometry (GC–MS) analysis. To determine the toxicity profile in Swiss albino mice, acute and subchronic toxicity experiments were performed according to Organisation for Economic Co-operation and Development criteria. A behavioral test in mice with drug-induced learning and memory impairment was performed to determine neuroprotective effects. Results: In the study GC–MS, 19 compounds were detected. Compared to the control group, no clinical signs of toxicity were detected in the plant-treated group in both the acute and subchronic toxicity experiments at the highest dose of 2,000 mg/ kg. It was calculated that the mean oral lethal dose (LD50) > was 2,000 mg/kg. Scopolamine-induced cognitive deficits in mice were greatly reduced after pretreatment with the EEAB at a dose of 100 mg/kg p.o. This was demonstrated by the reversal of the improvement in spontaneous alternation in the Y-maze task and by the significant improvement in latency in the passive avoidance task. Conclusion: Based on the results, EEAB might contain potent secondary metabolites that would primarily enhance the neuroprotective effects and cognitive deficits induced by cholinergic dysfunction.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Sundaram, D. P., Govindaswamy, S., S., S. S. K., Selvamani, P., & Latha, S. (2023). Aristolochia bracteolata Lam.’s Toxicity Profile and Neuroprotective Effects in Mice with Memory Impairment Triggered by Scopolamine. Journal of Pharmacology and Pharmacotherapeutics, 14(3), 238–245. https://doi.org/10.1177/0976500X231215933
